HiloProbe Overview
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Liquidation
HiloProbe General Information
Description
Operator of a research-based company intended to develop diagnostics medical techniques for cancer treatment. The company allows accurate analysis of the spread of cancer cells into lymph nodes as well as detection and characterization of lymph nodes of colorectal cancer, enabling doctors and medical professionals to understand about aggressive cancer cells are and select the appropriate treatment for the patient.
Contact Information
Website
www.hiloprobe.seCorporate Office
- Tvistevägen 48 C
- 907 36 Umeå
- Sweden
Corporate Office
- Tvistevägen 48 C
- 907 36 Umeå
- Sweden
HiloProbe Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Bankruptcy: Liquidation | 11-Nov-2024 | Completed | Bankruptcy: Liquidation | |||
| 7. Later Stage VC | 06-Nov-2024 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 5. Grant | 05-Oct-2020 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 01-Jan-2018 | Completed | Generating Revenue | |||
| 3. Grant | 30-Dec-2017 | Completed | Generating Revenue | |||
| 2. Grant | 31-Mar-2017 | $11.2K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 01-Jan-2012 | Completed | Startup |
HiloProbe Patents
HiloProbe Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2981481-T3 | Marker genes for colorectal cancer classification, method for judging lymph node metastasis for colorectal cancer prognosis and kit for it | Active | 20-Apr-2016 | ||
| AU-2017254347-A1 | Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor | Active | 20-Apr-2016 | ||
| AU-2017254347-B2 | Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor | Inactive | 20-Apr-2016 | ||
| EP-3446122-A1 | Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor | Active | 20-Apr-2016 | ||
| EP-3446122-A4 | Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor | Active | 20-Apr-2016 | C12Q1/6886 |
HiloProbe Signals
HiloProbe FAQs
-
Where is HiloProbe headquartered?
HiloProbe is headquartered in Umeå, Sweden.
-
What is the size of HiloProbe?
HiloProbe has 3 total employees.
-
What industry is HiloProbe in?
HiloProbe’s primary industry is Decision/Risk Analysis.
-
Is HiloProbe a private or public company?
HiloProbe is a Private company.
-
What is HiloProbe’s current revenue?
The current revenue for HiloProbe is .
-
How much funding has HiloProbe raised over time?
HiloProbe has raised $285K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process